Z-0534-2026 Class II Ongoing
FDA device recall Z-0534-2026 was initiated by Quest International, Inc. on Oct 1, 2025 and is designated Class II. Reason for recall: Due to distributing the measles IgG IVD without a premarket approved/cleared. The recall status is ongoing.
Recall details
- Product Type
- Devices
- Report Date
- Nov 26, 2025
- Initiation Date
- Oct 1, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Brand Name: ReQuest Measles IgG Product Name: Rubeola IgG Enzyme Linked Immunoabsorbant Assay Model/Catalog Number: 01-190 Software Version: N/A Product Description: Measles IgG tests, performed using ELISA (Enzyme-Linked Immunosorbent Assay) method, used to detect the presence of IgG antibodies against measles virus in a patient's serum or plasma Component: not a component
Reason for recall
Due to distributing the measles IgG IVD without a premarket approved/cleared.
Distribution pattern
All products were distributed in the United States. (Utah, Washington).
Code information
Lot Code: DI# 00850487007357 Lots affected: L07024 and E03025
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0534-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026